SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

14 Sep 2022 12:21

RNS Number : 4717Z
Rentokil Initial PLC
14 September 2022
 

Rentokil Initial plc (the Company)

The Company hereby announces that it has been notified that in respect of the interim dividend for the six months ended 30 June 2022, the following persons discharging managerial responsibility have acquired ordinary shares of 1 pence in the Company as detailed below as a result of their participation in the Company's Dividend Reinvestment Plan (DRIP). The shares were purchased on 13 September 2022 at £5.576874 each.

Name

Number of DRIP shares acquired

Vanessa Evans

1

Stuart Ingall-Tombs

628

Alain Moffroid

1,040

John Myers

1,500

Andy Ransom

373

 

The notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation and give further detail.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Vanessa Evans

2

 

Reason for the notification

 

a)

 

Position/status

 

Group HR Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£5.576874

1

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

1 share

 

£5.58

e)

 

Date of the transaction

 

13 September 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stuart Ingall-Tombs

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£5.576874

628

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

628 shares

 

£3,502.28

e)

 

Date of the transaction

 

13 September 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Alain Moffroid

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£5.576874

1,040

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

1,040 shares

 

£5,799.95

e)

 

Date of the transaction

 

13 September 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£5.576874

1,500

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

1,500 shares

 

£8,365.31

e)

 

Date of the transaction

 

13 September 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Andy Ransom

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£5.576874

373

d)

 

Aggregated information

 

- Aggregated volume

 

- Total price

 

 

 

373 shares

 

£2,080.17

e)

 

Date of the transaction

 

13 September 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

Enquiries:

 

Catherine Stead, Company Secretary Rentokil Initial plc 07826 533700

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDCIBBDGDS
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.